| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 180,200 | 455,432 | 779,644 | 311,751 | | Cost of Revenue | 99,362 | 285,479 | 558,961 | 224,104 | | | Gross Profit | 80,838 | 169,953 | 220,683 | 87,647 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 58,964 | 62,009 | 59,462 | 63,249 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 24,489 | 24,306 | 24,142 | 23,942 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,615) | 83,638 | 137,079 | 456 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,546) | 1,758 | (316) | (6,931) | | Earnings Before Interest And Taxes | 1,001 | 68,183 | 93,889 | (79,967) | | Interest Expense | 8,301 | 14,658 | 13,013 | 13,970 | | Income Before Tax | (7,300) | 53,525 | 80,876 | (93,937) | | Income Tax Expense | (3,334) | 35,044 | 52,664 | (7,238) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,300) | 53,525 | 80,876 | (13,207) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,300) | 53,525 | 80,876 | (13,207) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,300) | $53,525 | $80,876 | ($13,207) |
|
0.51% Nasdaq 
Income Statement
